Study: Cholesterol substantially reduced with oral PCSK9 inhibitor
A new study led by Baylor College of Medicine and presented at the American College of Cardiology's Annual Scientific Session together with World Congress of Cardiology found that an oral PCSK9 inhibitor called MK-0616 reduced ...
Mar 7, 2023
0
3